UniSuper Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
UniSuper Management's RMD Position: Q1 2026 in Review
UniSuper Management reduced its ResMed (RMD) stake by 7.2% in Q1 2026, selling an estimated $1.2M and leaving 62,329 shares worth $14M. The position accounts for 0.09% of the portfolio, ranked #140.
UniSuper Management first reported a position in RMD in Q2 2023 and has held it in 12 quarters since. The position peaked at $19M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- UniSuper Management held 62,329 shares of ResMed worth $14M as of Q1 2026.
- UniSuper Management sold 4,801 ResMed shares in Q1 2026, an estimated $1.2M.
- ResMed made up 0.09% of UniSuper Management's portfolio in Q1 2026, its #140 holding.
- UniSuper Management first reported a position in ResMed in Q2 2023 and has held it in 12 quarters since.
- UniSuper Management's ResMed position peaked at $19M in Q3 2025.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on UniSuper Management's 13F filing for Q1 2026, filed 11 May 2026.